Microbial Products: Technologies, Applications and Global Markets
April 26, 2011
Wellesley, Mass. – According to a new technical market research report, MICROBIAL PRODUCTS: TECHNOLOGIES, APPLICATIONS AND GLOBAL MARKETS (BIO086A) from BCC Research (www.bccresearch.com), the global market value for microbial products is an estimated $156 billion in 2011, but is expected to increase to more than $259 billion in 2016, for a 5-year compound annual growth rate (CAGR) of 10.7%.
The largest segment of the market, microbial products, has an estimated value of $151 billion in 2011 and is expected to increase at a CAGR of 10.8% to reach $252 billion in 2016.
The other segment, microbes, is projected to reach $6.8 billion in 2016, after rising at a CAGR of 6.9% from its estimated value of nearly $4.9 billion in 2011.
A microbe is a minute living organism, such as a bacterium, yeast, or fungus. The first commercial applications of microbes date back to around 1750 BC, when the ancient Sumerians used yeast to brew beer. Microbes were used for centuries to produce bread, wine, vinegar, and other common products, without anyone knowing the scientific basis for the production.
Genetically engineered microbes are used for the commercial production of nonmicrobial products such as insulin, interferon, human growth hormone, and viral vaccines. Microbes are also used to produce energy (e.g., biodiesel and bioethanol) and clean up environmental pollutants such as sewage and oil spills. As the active ingredient in biofertilizers and biopesticides, microbes contribute to increasing agricultural productivity, and microbes form the basis of cost-effective methods of mining and metallurgy.
The goal of this report is to survey microbial applications in a wide range of fields, identify the applications that appear to have significant commercial potential in the near- to mid-term, and develop quantitative estimates of their current and/or future sales.
This report’s specific objectives support this broad goal. These objectives include identifying microbial technologies and applications that have the greatest commercial potential in the 2010-2016 time frame, identifying market drivers, evaluating obstacles to their successful commercialization, and projecting future sales of each application.
This report is intended especially for biotechnology marketing executives, entrepreneurs, investors, venture capitalists, and other readers with a need to know where the market for microbial technologies and products is headed over the next 5 years.
Microbial Products: Technologies, Applications and Global Markets( BIO086A )
Publish Date: Apr 2011
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development
Reports from Cell Biology
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum